EPIME
ABBV icon

Evelyn Partners Investment Management (Europe)’s AbbVie ABBV Stock Holding History

Evelyn Partners Investment Management (Europe)’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$356K Hold
1,635
– – 0.12% 71
2025
Q4 		$374K Sell
1,635
-125
-7% -$28.5K 0.12% 71
2025
Q3 		$408K Hold
1,760
– – 0.14% 65
2025
Q2 		$327K Hold
1,760
– – 0.12% 74
2025
Q1 		$369K Hold
1,760
– – 0.14% 70
2024
Q4 		$313K Buy
+1,760
New +$324K 0.11% 74

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Evelyn Partners Investment Management (Europe)'s ABBV Position: Q1 2026 in Review

Evelyn Partners Investment Management (Europe) held its AbbVie (ABBV) position steady in Q1 2026 at 1,635 shares worth $356K. The position accounts for 0.12% of the portfolio, ranked #71.

Evelyn Partners Investment Management (Europe) first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $408K in Q3 2025. 4,090 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Evelyn Partners Investment Management (Europe) held 1,635 shares of AbbVie worth $356K as of Q1 2026.
  • Evelyn Partners Investment Management (Europe) left its AbbVie share count unchanged in Q1 2026.
  • AbbVie made up 0.12% of Evelyn Partners Investment Management (Europe)'s portfolio in Q1 2026, its #71 holding.
  • Evelyn Partners Investment Management (Europe) first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • Evelyn Partners Investment Management (Europe)'s AbbVie position peaked at $408K in Q3 2025.
  • 4,090 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Evelyn Partners Investment Management (Europe)'s 13F filing for Q1 2026, filed 15 May 2026.